Russell Investments Group’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$269K	Buy	8,491 +1,349	+19%	+$36.8K	﹤0.01%	2748
2025 Q4	$194K	Sell	7,142 -220	-3%	-$5.79K	﹤0.01%	2854
2025 Q3	$190K	Buy	7,362 +5,047	+218%	+$117K	﹤0.01%	2830
2025 Q2	$47.1K	Buy	2,315 +501	+28%	+$9.75K	﹤0.01%	2996
2025 Q1	$32.9K	Buy	1,814 +9	+0.5%	+$201	﹤0.01%	3001
2024 Q4	$45.6K	Buy	1,805 +37	+2%	+$1K	﹤0.01%	2846
2024 Q3	$60.1K	Sell	1,768 -2,280	-56%	-$86.9K	﹤0.01%	2757
2024 Q2	$150K	Buy	4,048 +4,019	+13,859%	+$152K	﹤0.01%	2545
2024 Q1	$1.22K	Buy	+29	New	+$1.19K	﹤0.01%	3119
2018 Q3	–	Sell	-753	Closed	-$6K	–	2954
2018 Q2	$6K	Sell	753 -1,739	-70%	-$23.2K	﹤0.01%	2887
2018 Q1	$87K	Sell	2,492 -2,595	-51%	-$101K	﹤0.01%	2768
2017 Q4	$224K	Sell	5,087 -18,414	-78%	-$789K	﹤0.01%	2644
2017 Q3	$1.01M	Buy	23,501 +20,709	+742%	+$776K	﹤0.01%	2144
2017 Q2	$103K	Sell	2,792 -1,430	-34%	-$63.2K	﹤0.01%	2800
2017 Q1	$229K	Sell	4,222 -1,855	-31%	-$96.6K	﹤0.01%	2668
2016 Q4	$325K	Buy	+6,077	New	+$346K	﹤0.01%	2593